Search results
Results from the WOW.Com Content Network
Novavax successfully developed a COVID-19 vaccine that is currently its only product on the market. The company has been working on two other candidates. One is an investigational influenza vaccine.
COVID-19 vaccines gave Moderna, Pfizer and Johnson & Johnson a boost — but are the stocks still a good investment in 2021? Here's what to consider before buying in.
Shares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and 9.3%, respectively, through Thursday ...
It seems like just yesterday that vaccines used to combat the COVID-19 pandemic were all anyone in the medical world could talk about. Companies such as Pfizer, Moderna, and Johnson & Johnson ...
The news got even better last week, when the UK drug regulatory commission MHRA authorized Pfizer and BioNTech to distribute their Covid-19 mRNA vaccine for emergency use and the first doses could ...
In this article we will take a look at the 10 best vaccine stocks to buy now. You can skip our comprehensive analysis of the biopharma industry and go directly to the 5 Best Vaccine Stocks to Buy ...
An hour before the market closed Thursday, as news reports of Trump’s choice began trickling out, Covid-19 vaccine maker Moderna dipped as much as 6%, ... Pfizer stock has dipped 11%, and ...
In this article, we will discuss the 10 best vaccine stocks to buy now. If you want to explore similar stocks, you can also take a look at 5 Best Vaccine Stocks To Buy Now. One of the most ...